Nurse practitioners and physician assistants involved in the management of patients with GI disorders and chronic liver disease.
At the conclusion of this activity, participants will be able to:
- Compare the strength of data supporting the role of microbiota in various diseases
- Describe AGA's recommendations for probiotic use in various populations/underlying disease states
Release Date: 01/15/21
Expiration Date: 01/15/22
*This program has expired. CME credit is no longer available.
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 0.5 contact hours may be earned for successful completion of this activity.
Nurse Practitioner Statement
This program has been planned and implemented in accordance with the
Accreditation Standards of the American Association of Nurse Practitioners
(AANP) through the joint providership of the Annenberg Center for Health
Sciences at Eisenhower and Gastroenterology and Hepatology Advanced Practice
Providers. The Annenberg Center for Health Sciences at Eisenhower is accredited
by the American Association of Nurse Practitioners as an approved provider of
nurse practitioner continuing education. Provider number: 040207
This program is accredited for 0.5 contact hour(s). Program ID #5838
Physician Assistant Statement
This activity has been reviewed by the AAPA Review Panel and is compliant with
AAPA CME Criteria. This activity is designated for 7.5 AAPA Category 1 CME
credits. Approval is valid from 1/15/2021 to 1/15/2022. PAs should only claim
credit commensurate with the extent of their participation. AAPA reference
Please note, each session is eligible for 0.5 credits.
Disclosure of Conflicts of Interest
All individuals in control of the content of continuing education activities
provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are
required to disclose to the audience any real or apparent commercial financial
affiliations related to the content of the presentation or enduring material.
Full disclosure of all commercial relationships must be made in writing to the
audience prior to the activity. All other staff at the Annenberg Center for
Health Sciences at Eisenhower and GHAPP have no relationships to disclose.
Learner Assurance Statement
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving
all conflicts of interest issues that could arise as a result of individuals who
control activity content and who have relationships with drug or device
manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is
committed to retaining only those individuals with financial interests that can
be reconciled with the goals and educational integrity of the CME activity.
Dr. Susan T. Wolgamott
Speakers Bureau: AbbVie, Clinical Area - IBD, EPI, (previously Allergan) - IBS-D, IBS-C, CIC
Speakers Bureau: Salix, Clinical Area - IBS-D IBS-C, CIC, HE
Speakers Bureau: Ironwood, Clinical Area- IBS-D
Sub-Investigator: Clinical Research Institute of Michigan, Clinical Area - IBD, IBS-D, IBS-C, CIC, Chronic Pancreatitis, Gastroparesis, GERD, EoE, Colonoscopy Prep, NASH, Cirrhosis, HE, Celiac Disease, Smoking Cessation
This activity is supported by an educational grant from: AbbVie, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Pfizer Inc., and Takeda Pharmaceuticals U.S.A, Inc.